#AHA20 – Randomized trial: High-dose Omega-3 fatty acids did not reduce the risk of cardiac events in patients at high cardiovascular risk

Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial – JAMA

Editorial 1: Effects of Omega-3 Fatty Acids on Major Adverse Cardiovascular Events: What Matters Most: the Drug, the Dose, or the Placebo?

Editorial 2: Do Omega-3 Fatty Acids Benefit Health?

Commentary: STRENGTH trial finds new fish oil medication did not reduce the risk of cardiac events – American Heart Association

Commentary on Twitter

In this RCT, omega-3 fatty acids (EPA/DHA) did not reduce major adverse CV events vs corn oil in statin-treated patients at high CV risk
(Compare w Vascepa in REDUCE-IT) https://t.co/7BIs1Rr8YZ#STRENGTHTrial #AHA20 #SteveNissen@ProfSNicholls @Dmozaffarian @ClevelandClinic

— JAMA (@JAMA_current) November 15, 2020